Myeloproliferative Disorders

<p>With the recent discovery of JAK2 mutations in myeloproliferative disorders medical science has taken a revolutionary stride forward toward understanding the pathogenesis of these diseases. This new advancement translates not only to a more rapid and reliable diagnosis but also allows groundbreaking research into the development of new therapeutics. Written in an easy-to-follow text <i>myeloproliferative disorders </i>gives the practicing clinician a single source answer to classification diagnosis management and recent advances in this disorder.</p>